Your browser doesn't support javascript.
loading
Antigen-specific nanomedicines for the treatment of autoimmune disease: target cell types, mechanisms and outcomes.
Yang, Yang; Santamaria, Pere.
Affiliation
  • Yang Y; Julia McFarlane Diabetes Research Centre (JMDRC) and Department of Microbiology, Immunology and Infectious Diseases, Snyder Institute for Chronic Diseases and Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Alberta T2N 4N1 Canada; Department of Biochemistry and Molecular Biology and Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Alberta T2N 4N1, Canada. Electronic address: yyang@ucalgary.ca.
  • Santamaria P; Julia McFarlane Diabetes Research Centre (JMDRC) and Department of Microbiology, Immunology and Infectious Diseases, Snyder Institute for Chronic Diseases and Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Alberta T2N 4N1 Canada; Institut D'Investigacions Biomèdiques August Pi i Sunyer, Barcelona 08036, Spain. Electronic address: psantama@ucalgary.ca.
Curr Opin Biotechnol ; 74: 285-292, 2022 04.
Article in En | MEDLINE | ID: mdl-35007990
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autoimmune Diseases / Nanomedicine Limits: Animals Language: En Journal: Curr Opin Biotechnol Journal subject: BIOTECNOLOGIA Year: 2022 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autoimmune Diseases / Nanomedicine Limits: Animals Language: En Journal: Curr Opin Biotechnol Journal subject: BIOTECNOLOGIA Year: 2022 Document type: Article Country of publication: